Pushing The Frontiers of Human Cell Manufacturing — Mytos Announces $19M Series A
Newsroom
Mytos raises $19M in Series A funding
Mytos accelerates development of every new drug, by automating the most manual process in Biotech - growing human cells. We’re live in multibillion dollar Pharma and Biotechs on both US Coasts, and we’re just getting started.
READ MORE
This Startup Just Raised $19 Million To Bring An Industrial Revolution To Biology
Cell manufacturing company raises $19M Series A to increase capacity, staff numbers
Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth